About Real Drugs
Real Drugs was a Healthcare company based in Delhi (India). It produces high-quality generic dosage forms and active pharmaceutical ingredients (APIs). It operates on a B2B model. Its Indian entity Real Drugs Private Limited reported revenue of ₹2.04 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Generic Drugs and API Manufacturing.
Company details
Real Drugs, based in Delhi, focuses on providing healthcare solutions, producing pharmaceutical products, generic drugs, and api manufacturing. Produces high-quality generic dosage forms and active pharmaceutical ingredients (APIs). The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Delhi, India
- SectorsHealthcare
- Website realdrugs.in
- Legal Name Real Drugs Private Limited
- Date of Incorporation 08 Oct, 2004
- Jurisdiction Delhi, India
- Annual Revenue₹2.04 Cr
FY 2026 · -76% YoY
- Net Loss-₹26.7 Lakh
FY 2026 · -29% margin
- EBITDA₹1.07 Cr
FY 2026 · 116% margin
Associated legal entities of Real Drugs
Real Drugs operates through Real Drugs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Real Drugs Private Limited CIN U24239DL2004PTC129775 | Active | 08 Oct 2004 | Delhi, Delhi | ₹2.0 Cr | 3 | View details |
Board of directors of Real Drugs Private Limited (Real Drugs)
Real Drugs Private Limited is the primary company behind Real Drugs. The board of Real Drugs Private Limited currently have 3 directors; the longest-serving is Kapil Goyal, appointed in 2021. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kapil Goyal DIN 06360286 | Director | 23 Jun 2021 | 5 yrs 4 mo | Real Drugs Private Limited |
| Manoj Kumar Jha DIN 10776701 | Director | 19 Sep 2024 | 2 yrs 1 mo | Real Drugs Private Limited |
| Naresh Kumar Goyal DIN 00135922 | Director | 23 Sep 2024 | 2 yrs 1 mo | Real Drugs Private Limited |
Financials of Real Drugs
Figures of Real Drugs Private Limited, the primary company behind Real Drugs, for FY 2026. Revenue was ₹2.04 Cr (-76% year on year). Net loss was -₹26.7 Lakh (-29% margin). EBITDA was ₹1.07 Cr (116% margin). Revenue has grown at a compounded annual rate of +95% over three years and +7% over five years.
- ₹2.04 CrRevenue · FY 2026 · -76% YoY
- -₹26.7 LakhNet loss · -29% margin
- ₹1.07 CrEBITDA · 116% margin
- ₹1 LakhPaid-up capital
- +95%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Real Drugs Private Limited are on its company page.
Detailed financial statements for Real Drugs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Real Drugs
Real Drugs is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
The primary company behind Real Drugs, Real Drugs Private Limited, reported revenue of ₹2.04 Cr for FY 2026, down 76% year on year.
Real Drugs, based in Delhi, focuses on providing healthcare solutions, producing pharmaceutical products, generic drugs, and api manufacturing. Produces high-quality generic dosage forms and active pharmaceutical ingredients (APIs). The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Real Drugs operates through Real Drugs Private Limited.
The legal entities of Real Drugs currently have 3 directors, including Kapil Goyal, Manoj Kumar Jha, Naresh Kumar Goyal.